BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 620227)

  • 1. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.
    Melander A; Sartor G; Wåhlin E; Scherstén B; Bitzén PO
    Br Med J; 1978 Jan; 1(6106):142-4. PubMed ID: 620227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection.
    Braselton WE; Bransome ED; Huff TA
    Diabetes; 1977 Jan; 26(1):50-7. PubMed ID: 830565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 5. Glibenclamide therapy in diabetes mellitus.
    Bhattia SK; Hadden DR; Montgomery DA; Weaver JA
    Br Med J; 1970 Jun; 2(5709):570-2. PubMed ID: 5005518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLC determination of plasma levels of intact chlorpropamide or tolbutamide.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1976 Apr; 65(4):576-9. PubMed ID: 1271259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of rifampin and chlorpropamide.
    Self TH; Morris T
    Chest; 1980 Jun; 77(6):800-1. PubMed ID: 7398394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relative effectiveness of tolbutamide, chlorpropamide and gliclazide].
    Bernaś M; Czech A; Tatoń J
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):35-9. PubMed ID: 1409040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of blood serum lipid and lipoprotein indices in diabetes mellitus, treated with chlorpropamide and butamide].
    Sil'nitskiĭ PA
    Probl Endokrinol (Mosk); 1968; 14(3):9-13. PubMed ID: 5734589
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of glibenclamide, chlorpropamide and tolbutamide in plasma by high-performance liquid chromatography with ultraviolet detection.
    Zecca L; Trivulzio S; Pinelli A; Colombo R; Tofanetti O
    J Chromatogr; 1985 Apr; 339(1):203-9. PubMed ID: 3926803
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new hypoglycemic sulfonamide: AN1324].
    Vignalou J; Beck H
    Presse Med (1893); 1968 Oct; 76(38):1827-8. PubMed ID: 5737547
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.
    Shenfield GM; Logan A; Shirling D; Baird J
    Diabetologia; 1977 Aug; 13(4):367-71. PubMed ID: 913926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes mellitus treated with chlorpropamide and tolbutamide. A four-year clinical study.
    Powell T; Howells L
    Diabetes; 1966 Apr; 15(4):269-75. PubMed ID: 5929542
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chlorpropamide and other oral hypoglycemic agents in the treatment of diabetes mellitus resistant to tolbutamide. Clinico-statistical study].
    Danelon-Martina L
    Clin Ter; 1969 Apr; 49(2):135-46. PubMed ID: 5407314
    [No Abstract]   [Full Text] [Related]  

  • 17. Wide variation in serum chlorpropamide concentration in outpatients.
    Bergman U; Christenson I; Jansson B; Wiholm B-E ; Ostman
    Eur J Clin Pharmacol; 1980 Aug; 18(2):165-9. PubMed ID: 7428798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorpropamide and glibenclamide serum concentrations in hospitalized patients.
    Huupponen R; Viikari J; Saarimaa H
    Ann Clin Res; 1982 Jun; 14(3):119-22. PubMed ID: 6814340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Acta Med Scand; 1980; 208(4):301-7. PubMed ID: 6778079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparison of intravenous tolbutamide and insulin administration during and after operation in patients with maturity-onset diabetes (author's transl)].
    Fähndrich W; Liebermeister H; Schmitt H; Daweke H
    Dtsch Med Wochenschr; 1974 Jan; 99(4):121-7. PubMed ID: 4203796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.